Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05207644 · ClinicalTrials.gov registry record · Phase 2
Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation
A Phase 2 study, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT05207644: Completed Phase 2 study, sponsored by Gynuity Health Projects.
NCT05207644 is a Phase 2 study that has completed, run by Gynuity Health Projects. The registered enrollment target is 40 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05207644, a Phase 2 study, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
Study to determine if a user-friendly medical abortion regimen using letrozole and misoprostol is safe and acceptable.
Primary Outcome
To evaluate the safety profile of a user-friendly letrozole-misoprostol regimen.
Interventions
- DRUG 30 mg letrozole followed by 800 mcg misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-12-09 |
| Est. Completion | 2022-04-30 |
| Phase | Phase 2 |
What the finished NCT05207644 record still lists
NCT05207644 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which 30 mg letrozole followed by 800 mcg misoprostol is the first listed.
NCT05207644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05207644 about?
NCT05207644 is a clinical study titled "Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation". Study to determine if a user-friendly medical abortion regimen using letrozole and misoprostol is safe and acceptable.
What is the current status of trial NCT05207644?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2021-12-09. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT05207644?
The interventions under investigation include: 30 mg letrozole followed by 800 mcg misoprostol (DRUG).
Who is sponsoring clinical trial NCT05207644?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05207644's enrollment target sits among peer trials
40 1362nd of 2000 higher than 542 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI